InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: None

Tuesday, 07/14/2020 10:51:43 AM

Tuesday, July 14, 2020 10:51:43 AM

Post# of 426272
Case 3:20-cv-00421; Document 1; Filed 07/13/20

Nothing burger ...

On information and belief, and as stated in a letter dated June 1, 2020 sent by Defendants to Amarin (the “June Notice Letter”), Defendants prepared and filed patent certifications with the FDA in support of amended ANDA No. 209457 with the intention of seeking to market a generic version of the 0.5 gram strength of Amarin’s VASCEPA® product (“generic VASCEPA® 0.5 g product”), including within this judicial district. Amarin received the June Notice Letter on June 2, 2020.

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News